BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20307616)

  • 61. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
    Dhopeshwarkar AS; Nicholson RA
    Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cannabinoids--can what hurts you make you stronger? Commentary on the article by Alvarez et al. on page 653.
    Ferriero DM
    Pediatr Res; 2008 Dec; 64(6):590-1. PubMed ID: 19034198
    [No Abstract]   [Full Text] [Related]  

  • 64. The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas.
    Hashemi M; Bashi S; Zali A
    Mol Biol Rep; 2020 Jul; 47(7):5461-5467. PubMed ID: 32623617
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
    González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
    Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice.
    Ikeda H; Ikegami M; Kai M; Ohsawa M; Kamei J
    Neuroscience; 2013 Oct; 250():446-54. PubMed ID: 23892011
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
    Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors.
    Marini P; Cascio MG; King A; Pertwee RG; Ross RA
    Br J Pharmacol; 2013 Jun; 169(4):887-99. PubMed ID: 23711022
    [TBL] [Abstract][Full Text] [Related]  

  • 70. AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
    Hosohata Y; Quock RM; Hosohata K; Makriyannis A; Consroe P; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Feb; 321(1):R1-3. PubMed ID: 9083796
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans.
    Schley M; Ständer S; Kerner J; Vajkoczy P; Schüpfer G; Dusch M; Schmelz M; Konrad C
    Brain Res Bull; 2009 Jun; 79(5):333-7. PubMed ID: 19480992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells.
    Gholizadeh F; Ghahremani MH; Aliebrahimi S; Shadboorestan A; Ostad SN
    Iran Biomed J; 2019 Mar; 23(2):153-8. PubMed ID: 29883990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex.
    Sim-Selley LJ; Vogt LJ; Vogt BA; Childers SR
    Life Sci; 2002 Sep; 71(19):2217-26. PubMed ID: 12215369
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
    Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis.
    Marchalant Y; Brothers HM; Norman GJ; Karelina K; DeVries AC; Wenk GL
    Neurobiol Dis; 2009 May; 34(2):300-7. PubMed ID: 19385063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.
    Fattore L; Viganò D; Fadda P; Rubino T; Fratta W; Parolaro D
    Eur J Neurosci; 2007 Apr; 25(7):2191-200. PubMed ID: 17419755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
    Ruhl T; Karthaus N; Kim BS; Beier JP
    Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
    Lunn CA; Fine JS; Rojas-Triana A; Jackson JV; Fan X; Kung TT; Gonsiorek W; Schwarz MA; Lavey B; Kozlowski JA; Narula SK; Lundell DJ; Hipkin RW; Bober LA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
    Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
    Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.